Rare Disease Day Roundup 2022
This past February 28th marked Rare Disease Day (RDD) 2022, the globally-coordinated movement on rare diseases, which works towards equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease; the NMD4C would like to take this opportunity to share some of the campaigns and events hosted by members of the neuromuscular community for this year’s event.
Muscular Dystrophy Canada
To celebrate RDD MDC hosted an “Individually Rare, Collectively Common” campaign, spotlighting Canadians affected by different neuromuscular disorders (NMDs) and asking them the question: ‘what do you wish you knew when you were first diagnosed and how have you advocated for yourself along the way?’ Read the responses from Canadians affected by NMDs in this article on MDC’s website!
A huge thank you to the incredible individuals who shared their stories and helped raise awareness of rare disorders today on #RareDiseaseDay and every other day! If you missed some of the posts, you can find them all here https://t.co/xSfBEk8rV1 pic.twitter.com/OxP3OVQD3V
— Muscular Dystrophy Canada (@MD_Canada) February 28, 2022
Defeat Duchenne Canada
Defeat Duchenne Canada (formerly Jesse’s Journey) asked for the help of the Duchenne community in raising awareness of Duchenne muscular dystrophy on Rare Disease Day, through their social media campaign. You can see how they raised awareness online by:
- Following @defeatduchenne on Facebook, Twitter, Instagram, and LinkedIn
- View and share their posts from Monday, February 28th, as Duchenne ambassadors speak to what it’s like living with a rare disease.
“Nothing is impossible; you just need to find a new or different way to do it!” – Christopher from Ontario
Today is @rarediseaseday – RT and help raise awareness of #Duchenne #musculardystrophy: https://t.co/k47CplK7qK. pic.twitter.com/04Ze1X2PBJ
— Defeat Duchenne Canada (@defeatduchenne) February 28, 2022
ProDGNE
To raise awareness for GNE myopathy, the ProDGNE consortium shared a week-long #GNEMfacts campaign in the lead-up to RDD to raise awareness of this ultra rare disease. Curated by communications lead and Patient Representative at Gli Equilibristi HIBM Michela Onali, the campaign shares facts describing the clinical aspects of GNE myopathy, challenges in diagnosis and care, and GNE myopathy research.
#RareDiseaseDay is here!👐
🟢 Thanks for joining our #GNEMfacts campaign over the past week!
🟣 Keep sharing our posts throughout the day👉With your help we hope to be able to join the community🌎to raise awareness on #GNEMyopathy https://t.co/sK0LPhGez8https://t.co/6XzIwdoYPE pic.twitter.com/LLxCzD0kZd
— ProDGNE (@ProDGNE) February 28, 2022
Check out the video below to learn more about the ProDGNE consortium, which aims to advance the steps for impactful research in GNE Myopathy by expanding the GNE Myopathy research network and building a long term partnership where patients are central partners and key drivers in Research and Development. You can also visit ProDGNE’s website to learn more.
Myotonic Dystrophy Foundation
The Myotonic Dystrophy Foundation (MDF) is celebrating RDD by continuing their advocacy for people affected Myotonic dystrophy (DM1) to have equal social opportunity, non-discrimination in education and work, and equitable access to health, social care, diagnosis and treatment. MDF have shared a web page where you can access tools to empower advocacy for DM1, learn about possible clinical trials, join the Myotonic Dystrophy Family Registry, and Dm1 guidelines and publications.
This past year MDF recognized the inaugural International Myotonic Dystrophy Awareness Day on September 15th, in partnership with the members of the global alliance including the NMD4C and MDC. Learn more about MDF’s plans for this year’s event here.
This #RareDiseaseDay we advocate for
people living with #myotonicDystrophy to have equal social opportunity, non-discrimination in education and
work, and equitable access to health, social care,
diagnosis and treatment. Help raise awareness and more at https://t.co/RY7Kb5viZb pic.twitter.com/81Tm2LqtDL— Myotonic Dystrophy Foundation (@MyotonicStrong) February 28, 2022
Facioscapulohumeral muscular dystrophy (FSHD) Society
The FSHD Society have prepared a web page with helpful resources to join the chorus of FHSD community members telling their story on RDD and beyond, including ways to connect online, joining events, and staying informed by signing up for email updates and following the FSHD blog!
Today is #RareDiseaseDay! We hope you participate!
➡ Head to our Rare Disease Day toolkit. Download the images to share https://t.co/4XphvV41mf
➡ Use #RareDiseaseDay #FSHD and #CureFSHD
➡ Take this opportunity to share your FSHD experience with the world! pic.twitter.com/p1GfKSuQfO
— FSHD Society (@FSHDSociety) February 28, 2022
Charcot-Marie-Tooth Association
The Charcot-Marie-Tooth (CMT) Association launched a #ImNotGoingToApologizeFor campaign on social media to celebrate RDD. See the campaign below, and learn about how people affected by CMT overcome challenges associated with the disease.
#ImNotGoingToApologizeFor using the resources available to me to make me feel comfortable and confident in my body #RDDNIH #RareDiseaseDay2022 pic.twitter.com/lBX53MXITJ
— Charcot-Marie-Tooth Association (@cmtausa) February 28, 2022
Read next...
National Training Standards Approved for AFC in Neuromuscular Medicine
The Royal College has approved the National Training Standards for the AFC in Neuromuscular Medicine, enabling PGME offices to apply for program accreditation. This milestone follows the discipline’s initial recognition in 2022.
Expanding National Clinical Outcome Assessment Capacity with Train(e)d
NMD4C and MDC have launched Train(e)d. This initiative is part of NMD4C’s broader efforts to build national capacity in outcome measures and natural history research in support of consistent and high-quality clinical assessments across Canada.
Announcing the 2025 Collaborative Research Training Award Recipients!!!
We are excited to announce the recipients of the 2025 NMD4C Collaborative Research Training Awards which supports Canadian trainees in their efforts to advance neuromuscular disease research while strengthening national collaboration among neuromuscular research laboratories.
NMD4C Hosts 2nd Annual Basic Research Summer School at York University!
The NMD4C is excited to announce a new program for neuromuscular research trainees that will support collaboration opportunities between Canadian research labs.
